ALC
ABBV icon

Alexander Labrunerie & Co’s AbbVie ABBV Stock Holding History

Alexander Labrunerie & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362K Buy
1,440
+36
+3% +$7.75K 0.13% 80
2026
Q1 		$305K Sell
1,404
-2
-0.1% -$444 0.11% 93
2025
Q4 		$321K Buy
1,406
+84
+6% +$19.1K 0.12% 87
2025
Q3 		$306K Buy
1,322
+178
+16% +$36.2K 0.11% 83
2025
Q2 		$212K Sell
1,144
-43
-4% -$7.99K 0.09% 105
2025
Q1 		$249K Buy
+1,187
New +$231K 0.11% 89
2024
Q4 		– Sell
-1,094
Closed -$216K – 104
2024
Q3 		$216K Buy
+1,094
New +$204K 0.1% 92

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alexander Labrunerie & Co's ABBV Position: Q2 2026 in Review

Alexander Labrunerie & Co increased its AbbVie (ABBV) stake by 2.6% in Q2 2026, buying an estimated $7.75K and bringing the position to 1,440 shares worth $362K. The position accounts for 0.13% of the portfolio, ranked #80.

Alexander Labrunerie & Co first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Alexander Labrunerie & Co held 1,440 shares of AbbVie worth $362K as of Q2 2026.
  • Alexander Labrunerie & Co bought 36 AbbVie shares in Q2 2026, an estimated $7.75K.
  • AbbVie made up 0.13% of Alexander Labrunerie & Co's portfolio in Q2 2026, its #80 holding.
  • Alexander Labrunerie & Co first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alexander Labrunerie & Co's 13F filing for Q2 2026, filed 3 Aug 2026.